Reports
Reports
Sale
The global vaccine storage equipment market size was valued at USD 5.8 billion in 2022, driven by the increasing demand for temperature-controlled storage solutions for vaccine storage across the globe. The market size is anticipated to grow at a CAGR of 10.1% during the forecast period of 2023-2031 to achieve a value of USD 13.7 billion by 2031.
Vaccine storage is related to the proper vaccine storage and handling practices from their development to the administration. The 2-8 °C cold chain is the industry norm for vaccine storage and delivery. In low- and middle-income nations, this is utilized for all currently licensed human vaccinations from the US Food and Drug Administration (FDA). There are some diseases like smallpox, chickenpox, shingles, and one of the measles, mumps, and rubella II vaccinations that are exempt from this rule and are transported between 25 °C and 15 °C. Some vaccinations, including the COVID-19 vaccine, need to be stored at a colder temperature of between 80 and 60 °C.
The market for vaccine storage equipment is witnessing significant growth driven by a combination of factors, including the initiatives of prominent organizations like UNICEF, which has strategically installed walk-in cold rooms across various regions, ensuring the quality and availability of vaccines. Initiatives like this majorly support the market expansion. Moreover, the Federal Government's efforts to establish a mega storage facility for vaccines in Nigeria will significantly enhance accessibility to vaccines which will directly contribute to the global vaccine storage equipment market growth.
Collaborations such as the partnership between USAID and UNICEF have also played a crucial role by delivering vaccine refrigerators to support immunization campaigns in needful countries. The market is further influenced by innovative technological advancements, exhibited by the development of PHCbi brand pharmaceutical refrigerators and biomedical freezers. These advanced storage solutions are designed to meet the stringent requirements of high-value vaccines and biologics, offering reliability, uniform temperature control, and robust performance.
Additionally, the growing focus on research and development activities within the sector is contributing to the global vaccine storage equipment market share. An emerging trend is the increasing emphasis on needle-free vaccine delivery platforms, aimed at eliminating the need for frozen storage and improving global access to immunization. These trends collectively underscore the vaccine storage equipment market's dynamic landscape, driven by technological innovation, strategic partnerships, and an unwavering commitment to improving healthcare infrastructure on a global scale, further propelling the market growth.
Market Breakup by Product Type
Market Breakup by End User
Market Breakup by Region
The global vaccine equipment market growth is driven by the increasing investments by healthcare institutions and biopharmaceutical companies in vaccine research and development. The increasing investments by the governments for immunization programs in several countries have been a major factor driving the market growth as well. The increasing prevalence of infectious diseases, especially after COVID-19 is further propelling the market growth. The market is also driven by the widespread vaccination campaigns conducted by international health organizations. The increased introduction of new vaccines in the market is also majorly supporting the market growth. The increasing technological development of storage equipment for vaccines is majorly contributing to the market growth.
The rising awareness among people and healthcare professionals associated with early disease detection and prevention is also a major factor intensifying the market growth. The increasing focus of government on developing immunization programs to ensure the availability of enough vaccines for needful people is further responsible for the rising global vaccine equipment market share. The increasing investment in research and development activities and rising investments in biotechnological industry sectors for vaccine research are also among the major factors contributing to the market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Vaccine Storage Equipment Market Overview
3.1 Global Vaccine Storage Equipment Market Historical Value (2016-2022)
3.2 Global Vaccine Storage Equipment Market Forecast Value (2023-2031)
4 Global Vaccine Storage Equipment Market Landscape
4.1 Global Vaccine Storage Equipment Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Vaccine Storage Equipment Product Landscape
4.2.1 Analysis by Product Type
5 Global Vaccine Storage Equipment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Vaccine Storage Equipment Market Segmentation
6.1 Global Vaccine Storage Equipment Market by Product Type
6.1.1 Market Overview
6.1.2 Bags, Vials, Ampoules
6.1.3 Freezers
6.1.4 Refrigerators
6.2 Global Vaccine Storage Equipment Market by End User
6.2.1 Market Overview
6.2.2 Hospitals and Medical Institutes
6.2.3 Distributor and Logistics
6.2.4 Retailers
6.2.5 Others
6.3 Global Vaccine Storage Equipment Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Vaccine Storage Equipment Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Vaccine Storage Equipment Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Vaccine Storage Equipment Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Vaccine Storage Equipment Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Vaccine Storage Equipment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Haier Group Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Philipp Kirsch GmbH
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Eppendorf AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Thermo Fisher Scientific, Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 B Medical Systems
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cole-Parmer Instrument Company, LLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 PHC Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Helmer Scientific, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Evermed S.R.L.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Vestfrost Solutions
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 American Biotech Supply
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Arctiko A/S
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Labcold
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Vaccine Storage Equipment Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 5.8 billion in 2022, driven by the increasing research and development.
The market is anticipated to grow at a CAGR of 10.1% during the forecast period of 2023-2031, likely to reach a market value of USD 13.7 billion by 2031.
The increasing incidence of infectious diseases, especially post-COVID-19, has increased the awareness about the quick availability of vaccines, which is majorly backed by the appropriate storage systems for them to stay effective. This is a major factor driving the market growth.
The increasing interest of scientists in developing energy-efficient storage devices is a major trend influencing market growth.
The different products available in the market are bags, vials, ampoules, freezers, and refrigerators.
The end users include hospitals and medical institutes, distributors and logistics, and retailers, among others.
Key players involved in the market are Haier Group Corporation, Philipp Kirsch GmbH, Eppendorf AG, Thermo Fisher Scientific, Inc., B Medical Systems, Cole-Parmer Instrument Company, LLC, PHC Corporation, Helmer Scientific, Inc., Evermed S.R.L., Vestfrost Solutions, American Biotech Supply, Arctiko A/S, and Labcold.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.